Władysław Lasoń Selected Research

Inflammation (Inflammations)

1/2018	Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures.
10/2015	Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction is connected with their suppressive effect on NKT and CD8(+) T cells but not on TCR delta T cells.
1/2013	Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.
1/2013	Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Władysław Lasoń Research Topics

Disease

14	Neuroblastoma 12/2023 - 09/2003
10	Seizures (Absence Seizure) 01/2013 - 11/2003
8	Epilepsy (Aura) 01/2013 - 11/2005
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 09/2003
5	Mental Disorders (Mental Disorder) 10/2020 - 01/2005
5	Contact Dermatitis (Eczema, Contact) 01/2017 - 01/2012
4	Inflammation (Inflammations) 01/2018 - 01/2013
4	Schizophrenia (Dementia Praecox) 01/2012 - 11/2003
3	Neoplasms (Cancer) 10/2018 - 11/2009
3	Hypersensitivity (Allergy) 01/2013 - 01/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2023
2	Brain Ischemia (Cerebral Ischemia) 10/2022 - 03/2020
2	Treatment-Resistant Depressive Disorder 06/2020 - 11/2009
2	Depressive Disorder (Melancholia) 08/2019 - 01/2013
2	Insulin Resistance 03/2018 - 01/2013
2	Anhedonia 07/2017 - 01/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 01/2014
2	Hypercalcemia (Milk Alkali Syndrome) 11/2016 - 11/2006
2	Brain Diseases (Brain Disorder) 11/2016 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2013 - 11/2009
2	Psychotic Disorders (Schizoaffective Disorder) 01/2004 - 11/2002
1	Cognitive Dysfunction 01/2023
1	Ischemic Stroke 10/2022
1	Stroke (Strokes) 10/2022
1	Neuroinflammatory Diseases 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2020
1	Obesity 03/2018
1	Necrosis 01/2016
1	Drug Hypersensitivity (Drug Allergy) 06/2015
1	Parkinson Disease (Parkinson's Disease) 10/2014

Drug/Important Bio-Agent (IBA)

12	Antidepressive Agents (Antidepressants)IBA 10/2020 - 01/2007
9	Anticonvulsants (Antiepileptic Drugs)IBA 01/2013 - 01/2006
7	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2023 - 09/2003
6	Neuroprotective AgentsIBA 12/2023 - 09/2003
5	Calcitriol (Calcijex)FDA LinkGeneric 10/2022 - 09/2003
5	GlucocorticoidsIBA 03/2018 - 01/2007
5	NeurosteroidsIBA 09/2008 - 11/2003
4	CytokinesIBA 01/2021 - 11/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 09/2008
4	StaurosporineIBA 01/2017 - 07/2007
3	Insulin (Novolin)FDA Link 01/2023 - 01/2008
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2018 - 12/2004
3	Phosphotransferases (Kinase)IBA 01/2017 - 11/2003
3	HaptensIBA 10/2015 - 01/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2011 - 11/2002
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022 - 03/2005
2	Cholecalciferol (Vitamin D3)FDA Link 10/2022 - 11/2016
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2018 - 09/2008
2	Sucrose (Saccharose)IBA 07/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2012
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 09/2009
2	CorticosteroneIBA 01/2016 - 01/2011
2	AntigensIBA 10/2015 - 01/2013
2	Phenobarbital (Luminal)FDA Link 06/2015 - 01/2008
2	Phenytoin (Dilantin)FDA LinkGeneric 06/2015 - 01/2008
2	Lamotrigine (Lamictal)FDA LinkGeneric 06/2015 - 01/2008
2	Carbamazepine (Tegretol)FDA LinkGeneric 06/2015 - 01/2008
2	Potassium Channels (Potassium Channel)IBA 01/2013 - 11/2005
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2013 - 11/2009
2	N-Methylaspartate (NMDA)IBA 01/2013 - 11/2009
2	Progesterone FDA LinkGeneric 01/2013 - 07/2003
2	Desipramine (Pertofrane)FDA LinkGeneric 01/2013 - 11/2009
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 11/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 11/2009
2	SteroidsIBA 01/2010 - 09/2003
2	Dehydroepiandrosterone SulfateIBA 09/2008 - 11/2003
2	Topiramate (Topamax)FDA LinkGeneric 01/2008 - 01/2008
2	Pregnanolone (Allopregnanolone)IBA 11/2007 - 07/2003
2	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 07/2007 - 11/2006
2	Ion Channels (Ion Channel)IBA 01/2007 - 01/2006
2	Cocaine (Cocaine HCl)IBA 01/2004 - 11/2003
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	AntioxidantsIBA 09/2021
1	InflammasomesIBA 01/2021
1	Ketamine FDA LinkGeneric 06/2020
1	necrostatin-1IBA 03/2020
1	Tryptophan (L-Tryptophan)FDA Link 08/2019
1	KynurenineIBA 08/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2018
1	AZ 12216052IBA 10/2018
1	LigandsIBA 10/2018
1	metabotropic glutamate receptor 8IBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2018
1	Antineoplastic Agents (Antineoplastics)IBA 10/2018
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2018
1	tianeptine (Stablon)IBA 01/2018
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 01/2017
1	NanocapsulesIBA 09/2016
1	Zonisamide (Zonegran)FDA LinkGeneric 06/2015
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 06/2015
1	Primidone (Sertan)FDA LinkGeneric 06/2015
1	celastrolIBA 10/2014
1	UbiquitinIBA 10/2014

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2004
3	Drug Therapy (Chemotherapy) 10/2022 - 01/2011
1	Drug Tapering 10/2020
1	Intranasal Administration 10/2020